Relmada Therapeutics Inc Share Price

NASDAQ: RLMD

Small Cap

$1.61

-0.06

(-3.61%)

as on September 17, 2025 at 1:29 am IST

$₹

Relmada Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$1.45
Day's Price Range
$1.92
$1.61
9.94%
Downside
19.25%
Upside
52 Week's Low
52 Week's High
$0.24
52-Week Price Range
$3.98
$1.61
85.07%
Downside
147.20%
Upside

Relmada Therapeutics Inc share price movements today

Previous Close: $1.67
Open: $1.73
Volume: 2.2M
Day's Low - High: $1.45 - $1.92
52 Week Low - High: $0.24 - $3.98

Relmada Therapeutics Inc Historical Returns

1 Month Return: + 158.47 %
3 Month Return: + 135.84 %
1 Year Return: -44.88 %
3 Year Return: -95.1 %
5 Year Return: -95.66 %

Relmada Therapeutics Inc Stock Fundamentals & Key Indicators

Check Relmada Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$52.8M

EPS (TTM)

-1.15

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

EBITDA

-161.2M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

2240000.00%

Relmada Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Relmada Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Relmada Therapeutics Inc	BUY	$52.8M	-95.66%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Relmada Therapeutics Inc Stock including INR - Dollar returns

The Relmada Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Relmada Therapeutics Inc investment value today

Current value as on today

₹58,003

Returns

₹41,997

(-42%)

Returns from Relmada Therapeutics Inc Stock

₹46,865 (-46.86%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Relmada Therapeutics Inc Stock

Based on 11 analysts

BUY

63.64%

Buy

36.36%

Hold

0.00%

Sell

Based on 11 analysts, 63.64% of analysts recommend a 'BUY' rating for Relmada Therapeutics Inc. Average target price of $1

Relmada Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Relmada Therapeutics Inc.

What analysts predicted

-61%DOWNSIDE

Target Price

Current Price

$1.61

Analyzed by

11 Analysts

Target

$1.00

Relmada Therapeutics Inc target price $1, a slight downside of -61% compared to current price of $1.61. According to 11 analysts rating.

Relmada Therapeutics Inc Stock's Interest Amongst Investors

Investment in Relmada Therapeutics Inc Shares on INDmoney has grown by 1250.00% over the past 30 days, indicating increased transactional activity.

Time period: August 18, 2025 to September 17, 2025

Change:1250.00% versus previous 30 day period

Search interest for Relmada Therapeutics Inc Stock has increased by 559% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:559% versus previous 30 day period

Relmada Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-
Operating Income	-28	-26	-22	-26	-22	-18	-23	-19	-18	-10
EBITDA	-28	-25	-22	-25	-19	-18	-23	-18	-18	-10
Interest Expense	1	1	-	-	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	-	-
Income Before Tax	-26	-25	-22	-25	-21	-17	-21	-18	-17	-9
Income Tax Expense	-1	-1	-1	0	-22	-18	-	-	-	-
Net Income	-26	-25	-22	-25	-21	-17	-21	-18	-17	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Relmada Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2019	Dec 2020	Jun 2021	Dec 2021	Jun 2022	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	0	-	0	-	-	-	-
Operating Income	-	-60	-	-125	-	-161	-103	-83
EBITDA	-	-59	-	-125	-	-157	4	-79
Interest Expense	-	1	-	0	-	4	-	-
Depreciation	-	0	-	0	-	-	-	-
Income Before Tax	-	-59	-	-125	-	-157	-98	-79
Income Tax Expense	-	-1	-	0	-	-2	0	-
Net Income	-17	-59	-59	-125	-125	-157	-98	-79
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Relmada Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-25	-22	-25	-21	-17	-21	-18	-17	-9
Operating Cash Flow	-13	-11	-10	-13	-13	-16	-8	-18	-6
Investing Cash Flow	-1	3	7	10	14	16	11	15	6
Financing Cash Flow	-	-	0	0	-	0	0	-	0
Change in Cash	-14	-7	-2	-2	0	0	2	-2	0

Relmada Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-6	-8	-59	-125	-157	-98	-79
Operating Cash Flow	-13	-6	-6	-27	-91	-103	-51	-51
Investing Cash Flow	0	0	0	-34	-54	19	50	51
Financing Cash Flow	0	0	6	28	187	45	0	0
Change in Cash	-13	-6	0	-33	41	-39	-1	0

Global Institutional Holdings in Relmada Therapeutics Inc

Funds	Holdings
Acadian Asset Management LLC	3.7%
Vanguard Group Inc	3.64%
BlackRock Inc	1.71%
Palo Alto Investors, LLC	1.49%
Geode Capital Management, LLC	0.91%

See all

Insights on Relmada Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 month, RLMD stock has moved up by 158.5%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 206.6%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 119.7%

About Relmada Therapeutics Inc

relmada therapeutics (otcqb: rlmd) is a clinical-stage, publicly traded specialty pharmaceutical company developing novel versions of proven drug products together with new chemical entities that potentially address areas of high unmet medical need in the treatment of chronic pain. relmada has a diversified portfolio of four lead products at various stages of development including d-methadone (rel-1017) its n-methyl-d-aspartate (nmda) receptor antagonist for neuropathic pain; topical mepivacaine (rel-1021), its orphan drug designated topical formulation of the local anesthetic mepivacaine; oral buprenorphine (rel-1028) its oral dosage form of the opioid analgesic buprenorphine; and levocap er (rel-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol. relmada’s product development efforts are guided by the internationally recognized scientific expertise of our research team. relmada’s approach is expected to reduce clinical development risks and

Organisation	Relmada Therapeutics Inc
Headquarters	2222 Ponce de Leon Blvd., Coral Gables, FL, United States, 33134
Industry	Pharmaceuticals: Major
CEO	Dr. Sergio Traversa M.B.A., Pharm.D.
E-voting on shares	Click here to vote

Key Management of Relmada Therapeutics Inc

Name	Title
Dr. Andrew Cutler	Senior Clinical Development Advisor
Dr. Richard M. Mangano Ph.D.	Consultant
Dr. Sergio Traversa M.B.A., Pharm.D.	CEO & Director
Mr. Maged S. Shenouda M.B.A., R.Ph.	Chief Financial Officer
Mr. Paul E. Kelly M.B.A.	COO & Director
Mr. Charles S. Ence CPA, M.B.A.	Chief Accounting & Compliance Officer
Ms. Gina DiGuglielmo	VP & Head of Clinical Operations
Dr. Raj S. Pruthi F.A.C.S., M.D., M.H.A.	Chief Medical Officer of Urology

FAQs

What is Relmada Therapeutics Inc share price today?

Relmada Therapeutics Inc share price today is $1.61 as on September 17, 2025 at 1:29 am IST at the close of the market. Relmada Therapeutics Inc share today touched a day high of $1.92 and a low of $1.45.

What is the 52 week high and 52 week low for Relmada Therapeutics Inc share?

Relmada Therapeutics Inc share touched a 52 week high of $3.98 on October 28, 2024 and a 52 week low of $0.24 on March 3, 2025. Relmada Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $1.61,which is 59.55% down from its 52 week high and 569.72% up from its 52 week low.

What is Relmada Therapeutics Inc's market capitalisation today?

Relmada Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Relmada Therapeutics Inc Stock (RLMD) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Relmada Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Relmada Therapeutics Inc Shares that will get you 0.9317 shares as per Relmada Therapeutics Inc share price of $1.61 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Relmada Therapeutics Inc Stock (RLMD) from India?

Indian investors can start investing in Relmada Therapeutics Inc (RLMD) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 8:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Relmada Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 8:40 am IST). Based on Relmada Therapeutics Inc share’s latest price of $1.61 as on September 17, 2025 at 1:29 am IST, you will get 6.2112 shares of Relmada Therapeutics Inc. Learn more about fractional shares .

What are the returns that Relmada Therapeutics Inc has given to Indian investors in the last 5 years?

Relmada Therapeutics Inc stock has given -95.66% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?